Learn More
Medchemexpress LLC FHT-1015 | 2368903-18-6 | 98.4% | C25H25N5O4S3 | 50 MG

Supplier: Medchemexpress LLC HY14489650MG
FHT-1015 is a selective inhibitor of SMARCA4 and SMARCA2, also known as BRG1 and BRM. It functions as an allosteric inhibitor, inducing a conformational change in the BRG1/BRM protein at an allosteric site, thereby inhibiting ATPase activity. This compound has been shown to interfere with tumor cell growth and migration and is a subject of research for uveal melanoma and hematologic cancer.
- Interferes with tumor cell growth and migration
- Subject of research for uveal melanoma
- Subject of research for hematologic cancer
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.